Erik Kinnman is a licensed physician with specialist expertise in neurology and pain management. He holds a PhD and is an Associate Professor at Karolinska Institutet.
Erik brings over 30 years of experience in senior leadership roles within the Life Science sector, with a strong combination of scientific, clinical, and business expertise. He has previously served as CEO of Sprint Bioscience and Abliva AB, and has held leading positions at AstraZeneca and SOBI, and has experience from the financial sector as a healthcare analyst at Danske Bank. Erik curently also serves as CEO of Vivesto AB and as Chairman of the Board of Edvince AB.